MicroRNA-217 modulates inflammation, oxidative stress, and lung injury in septic mice via SIRT1

Jie Yan1, Fan Yang1, Dengyun Wang1

  • 1Department of Thoracic and Cardiovascular Surgery, Huangshi Central Hospital (Affiliated Hospital of Hubei Polytechnic University), Edong Healthcare Group, Huangshi, Hubei, China.

Free Radical Research
|November 19, 2020
PubMed

Insights

MicroRNA-217 (miR-217) plays a key role in septic lung injury by regulating inflammation and oxidative stress. Targeting miR-217 offers a potential therapeutic strategy for this condition.

Area of Science:

  • Molecular Biology
  • Immunology
  • Pathology

Background:

  • Septic lung injury involves inflammation and oxidative stress.
  • The specific role of microRNA-217 (miR-217) in septic lung injury pathogenesis is unclear.
  • miR-217 is known to influence inflammatory and oxidative stress responses.

Purpose of the Study:

  • To investigate the role and mechanism of miR-217 in septic lung injury.
  • To determine if miR-217 can be a therapeutic target for septic lung injury.

Main Methods:

  • Sepsis was induced in mice using caecal ligation and puncture.
  • miR-217 expression was modulated using antagomirs and agomirs in vivo and in vitro.
  • Primary peritoneal macrophages were stimulated with lipopolysaccharide (LPS) for in vitro studies.
  • SIRT1's involvement was assessed through inhibition experiments.

Main Results:

  • miR-217 expression was found to be upregulated in septic lungs and macrophages.
  • Inhibiting miR-217 (antagomir) reduced inflammation and oxidative stress in sepsis models.
  • Enhancing miR-217 (agomir) exacerbated inflammation and oxidative stress.
  • SIRT1 mediated the anti-inflammatory and anti-oxidant effects of miR-217 inhibition.

Conclusions:

  • miR-217 is upregulated during septic lung injury and contributes to its progression.
  • Modulating miR-217 levels, particularly through inhibition, demonstrates therapeutic potential.
  • The miR-217/SIRT1 axis is a critical pathway in septic lung injury, highlighting miR-217 as a therapeutic target.

Related Concept Videos